Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NHIP (neuronal hypoxia inducible, placenta associated) is a primate-specific gene originally identified as LOC105373085 at chromosomal region 22q13.33. NHIP expression is induced by hypoxia and oxidative stress specifically in differentiated neurons and placental tissue. It regulates other genes involved in neuronal development, cell proliferation, and response to cellular stress. NHIP appears to play a protective role; reduced NHIP expression or activity in placenta and developing brain tissue is associated with increased risk for autism spectrum disorder (ASD), presumably due to decreased buffering of oxidative stress during development. It is currently under study as a potential biomarker for neurodevelopmental risk, but it is not considered a classic drug target type (such as a receptor or enzyme).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuronal hypoxia inducible, placenta associated (NHIP).